100 Results:
10/22/2025
Response to the Draft Report of the Health Economics Methods Advisory (HEMA): “Defining Appropria…
Report
10/21/2025
Patient Preferences for Attributes of Bispecific Antibodies for Relapse/Refractory Diffuse Large …
Article
10/13/2025
Jason Shafrin Interviewed in ‘Patti’s People’ Episode on Improving Healthcare Outcomes
In the news
09/17/2025
Imaging Utilization and Treatment Patterns of Brain Metastases in Patients With Non-Small Cell Lu…
Report
09/04/2025
Caregiver Risk Preferences for Delaying Loss of Ambulation in Duchenne Muscular Dystrophy in the …
Article
08/27/2025
Perspectives from the Healthcare Economist: CMS Doesn’t Consider QALYs – What’s a Health Economis…
Article
08/04/2025
A Structured Approach for Identifying Disease Analogs for Pulmonary Arterial Hypertension
Article
07/10/2025
Perspectives from the Healthcare Economist: Why CMS/AHIP’s Prior Authorization Changes Won’t Hurt…
Article
07/02/2025
Cost-Effectiveness Analysis Model for Sotagliflozin Compared with Insulin Monotherapy for Patient…
Article
07/01/2025
Quantifying the Value of Orphan Drugs and the Impact of the IRA Sole Orphan Exclusion
Report
06/25/2025
Cost Impact of Bruton’s Tyrosine Kinase Inhibitor Selection in Medicare Patients with Chronic Lym…
Article
06/18/2025
Inequalities in CAR T-Cell Therapy Access for US Patients with Relapsed/Refractory DLBCL: A SEER-…
Article
06/06/2025
New Commentary: Understanding a Major Change to U.S. Drug Pricing Policy
Article
05/29/2025
ISPOR 2025 Research Presentation Award
In the news